1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Microscopic Polyangiitis (MPA): new trials by email Literature Review of Microscopic Polyangiitis (MPA) trials Research Report on Microscopic Polyangiitis (MPA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA IFX-1 low dose, IFX-1 high dose, Placebo - Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA) | Phase 2 | Terminated | InflaRx GmbH | 20 | 2018-10-15 | 2022-05-26 |
Granulomatosis with Polyangiitis (1) · Microscopic Polyangiitis (1)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Autoimmune Diseases (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebral Small Vessel Diseases (1) · Cerebrovascular Disorders (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Interstitial (1) · Nervous System Diseases (1) · Respiratory Tract Diseases (1) · Skin Diseases (1) · Skin Diseases, Vascular (1) · Skin and Connective Tissue Diseases (1)
vilobelimab (1)
InflaRx GmbH (1)
Canada (1) · United States (1)
Korinna Pilz, MD, MS (1) · Peter A. Merkel, MD, MPH (1)